Oncoloxía médica
Servizo
National and Kapodistrian University of Athens
Atenas, GreciaPublicacións en colaboración con investigadores/as de National and Kapodistrian University of Athens (6)
2022
-
A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial
Annals of Oncology, Vol. 33, Núm. 2, pp. 181-192
2020
2019
-
Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)
Oncologist, Vol. 24, Núm. 4, pp. 491-497
2014
-
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
Cancer, Vol. 120, Núm. 10, pp. 1453-1461
2007
-
Bias in association studies of systemic lupus erythematosus susceptibility due to geographical variation in the frequency of a programmed cell death 1 polymorphism across Europe
Genes and Immunity, Vol. 8, Núm. 2, pp. 138-146